While the current findings support minimal diminished cytokine expression, the changes in disease activity were not statistically analyzed; therefore, the findings in this study may be insufficient to accurately assess the therapeutic potential of targeting RIPK1 in psoriasis. The gene discussed is RIPK1; the disease is psoriasis.